Circulating cell-free DNA sequencing for early detection of lung cancer-Reference-Cited by-全球学者库

Circulating cell-free DNA sequencing for early detection of lung cancer

Published:2023-07-03 Issue:7 Volume:23 Page:589-606
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Xue Ruyue¹,Yang Lu²³,Yang Meijia¹,Xue Fangfang²³,Li Lifeng¹,Liu Manjiao²³,Ren Yong²³,Qi Yu⁴,Zhao Jie¹

Affiliation:

1. Internet Medical and System Applications of National Engineering Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

2. State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, Jiangsu, China

3. Nanjing Simcere Medical Laboratory Science Co, Ltd, Nanjing, Jiangsu, China

4. Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

Funder

the Collaborative Innovation Major Project of Zhengzhou

The National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2023.2224504

Reference77 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. World Health Organization (WHO). Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, p. 2000–2019 (2020).

3. The National Lung Screening Trial: Overview and Study Design

4. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

5. Lung cancer